TENAX THERAPEUTICS INC Chart calendar Tenax Therapeutics Inc
1401c8ed90166fb.7rww4vjwXaE_tF0qwKsDjKqQOYF-Tv81qLbW9k-FlpY.h_5Em8-WJ-R31zp9k_J7w9_3Du4PFr5f0OHnkwDv1M_b7R2Rtohq73T9Kg~e7cb90c72ddd06c499c6b517d97d1130
Upcoming events on Tenax Therapeutics Inc
Past events on Tenax Therapeutics Inc
| 14/05/2024 05:30 pm | Q1 2024 Earnings Release |
| 18/04/2024 07:30 pm | Investor Meeting - Key Opinion Leader |
| 28/03/2024 06:00 pm | Q4 2023 Earnings Release |
| 19/03/2024 03:30 am | ROTH Conference |
| 06/03/2024 08:09 pm | Technology and Heart Failure Therapeutics Conference |
| 03/01/2024 | Reverse Split: 1 of 80 |
| 30/11/2023 | Extraordinary Shareholders Meeting |
| 05/01/2023 | Reverse Split: 1 of 20 |
| 02/04/2022 | American College of Cardiology Meeting |
| 31/03/2022 06:00 pm | FY 2021 Earnings Release |
| 05/01/2022 | LifeSci Partners Corporate Access Event |
| 16/11/2021 07:00 pm | Q3 2021 Earnings Release |
| 29/09/2021 11:05 pm | Benziga Healthcare Small Cap Conference |
| 13/09/2021 04:30 pm | H.C. Wainwright Global Investment Conference |
| 17/08/2021 05:30 pm | Interim 2021 Earnings Release |
| 16/08/2021 07:30 pm | Investor Meeting - Key Opinion Leader |
| 10/06/2021 | Annual General Meeting |
| 18/05/2021 02:45 am | Q1 2021 Earnings Release |
| 01/04/2021 02:15 am | FY 2020 Earnings Release |
| 09/03/2021 05:30 pm | H.C. Wainwright Global Life Science Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -9,86 -8,90 -10.83% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -8,56 -8,25 -3.7% | -9,87 -8,90 -10.88% | -32,7 -33,6 2.45% | -11,1 -12,0 7.92% | -8,23 -7,39 -11.47% | -19,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,39 -8,40 0.07% | -9,85 -8,90 -10.69% | -32,5 -33,5 2.92% | -11,0 -12,0 7.96% | -7,71 -7,18 -7.35% | -19,3 |
|
Net income Million USD | Released Forecast Spread | -8,39 -11,9 29.16% | -9,85 -8,90 -10.69% | -32,5 -33,5 2.92% | -11,0 -12,0 7.96% | -7,71 -7,18 -7.35% | -19,3 |
|
EPS USD | Released Forecast Spread | -2 160 -2 488 13.18% | -2 128 -1 352 -57.4% | -2 528 -2 600 2.77% | -601 -745 19.33% | -31,0 -28,8 -7.78% | -8,18 |
| Announcement Date | 30/03/20 | 31/03/21 | 29/03/22 | 31/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | |
|
EBIT Million USD | Released Forecast Spread | -3,21 -4,05 20.7% | -2,86 -2,50 -14.48% | -2,92 -3,25 10.23% | -2,55 -3,50 27.09% | -1,54 -2,63 41.53% | -1,24 -2,07 40.15% | -2,12 -2,60 18.56% | -3,34 -2,49 -34.15% | -3,91 -3,51 -11.44% | -4,47 | -5,14 | -5,93 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,21 -4,05 20.73% | -2,86 -2,50 -14.44% | -2,92 -3,25 10.26% | -2,55 -3,50 27.25% | -1,41 -2,63 46.57% | -1,11 -2,07 46.44% | -1,97 -2,60 24.15% | -3,23 -2,49 -29.52% | -3,80 -3,51 -8.32% | -4,47 | -5,14 | -5,93 | |
|
Net income Million USD | Released Forecast Spread | -3,21 -4,05 20.73% | -2,72 | -2,86 -2,50 -14.44% | -2,92 -3,25 10.26% | -2,55 -3,50 27.25% | -1,41 -2,63 46.57% | -1,11 -2,07 46.44% | -1,97 -2,60 24.15% | -3,23 -2,49 -29.52% | -3,80 -3,51 -8.32% | -4,47 | -5,14 | -5,93 |
|
EPS USD | Released Forecast Spread | -64,0 -256 75% | -176 | -176 -144 -22.22% | -176 -168 -4.76% | -72,8 -212 65.73% | -12,0 -29,6 59.46% | -4,00 -8,00 50% | -6,40 -9,60 33.33% | -8,64 -8,15 -6.08% | -3,12 -2,40 -30% | -2,25 | -2,47 | -1,42 |
| Announcement Date | 29/03/22 | 16/05/22 | 11/08/22 | 10/11/22 | 31/03/23 | 15/05/23 | 14/08/23 | 13/11/23 | 28/03/24 | 14/05/24 | - | - | - |
| 15/07/2024 11:15 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 22/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 24/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 10:30 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 26/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 10:30 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Tenax Therapeutics Inc
| 30/05/2024 01:31 am | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 04:30 pm | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 10:30 am | EVOTEC SE: Q1 2024 Earnings Release |
| 22/05/2024 02:44 am | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 04:30 pm | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 11:30 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 16/05/2024 01:35 am | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 04:30 pm | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 15/05/2024 01:35 am | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
